he would receive 6% royalties... the royalty is strictly for practising the original patent, US royalties normally stop at that patent’s expiry for US sales.
So that explains Missling's decade delay...He was trying to save 6%.
Anavex have of course since filed and have had granted all sorts of derivative innovative step patents, but they can't simply patent the original compound that he Vamvakides patent covered.